Samy Zaky | Immunology and Microbiology | Best Academic Researcher Award

Samy Zaky | Immunology and Microbiology | Best Academic Researcher Award

Mr Samy Zaky, Al-Azhar University, Al-Zahraa Hospital, Egypt

Prof. Samy Zaky Elsayed Kersh, born on December 15, 1955, is a distinguished medical professional specializing in endemic diseases. He earned his Bachelor of Medicine and Surgery from Al-Azhar University in 1982, followed by a Master’s degree in Tropical Medicine and Health from Cairo University in 1991 and a Ph.D. in Endemic Diseases from Al-Azhar University in 1999. His career spans decades of dedicated service in the medical field, including roles as a physician, specialist, and consultant. He later transitioned into academia, serving as a lecturer, assistant professor, and professor at Al-Azhar University. His expertise in endemic diseases has been instrumental in medical research and education. Currently, he is a Professor Emeritus at Al-Azhar University (Girls), Cairo, where he continues to contribute to medical advancements. His work focuses on diagnosing and treating endemic diseases, with a strong commitment to medical education and research.

Publication Profile

google scholar

Education 🎓

Prof. Samy Zaky Elsayed Kersh pursued his medical education with distinction. He obtained his Bachelor of Medicine and Surgery in December 1982 from Al-Azhar University, graduating with a “Good” grade. His passion for tropical medicine led him to earn a Master’s degree in Tropical Medicine and Health in November 1991 from Cairo University, achieving a “Very Good” grade. To further his expertise, he completed a Ph.D. in Endemic Diseases in November 1999 at Al-Azhar University. His educational journey laid the foundation for his contributions to the field of endemic diseases, focusing on research, treatment, and prevention. His academic credentials reflect his dedication to advancing medical knowledge and improving healthcare, particularly in endemic diseases that affect populations in tropical and subtropical regions. His qualifications have enabled him to hold key positions in both clinical practice and academia, making significant contributions to medical education and research.

Experience

Prof. Samy Zaky Elsayed Kersh has an extensive career spanning over four decades in both clinical practice and academia. He started as a Resident Physician at Al-Hussein University Hospital in 1983, later serving as a Physician at the Ministry of Health and a Resident at Hamiat Imbaba Hospital. He rose through the ranks, becoming an Assistant Specialist in 1989, Specialist in 1997, and Consultant in 2001. His academic career began in 2001 as a Lecturer at Al-Azhar University, progressing to Assistant Professor in 2004 and Professor in 2009. He also held administrative roles, serving as Acting Head of the Endemic Diseases Department in 2005. In 2016, he was appointed Professor at Al-Azhar University (Girls), Cairo, and later became Professor Emeritus. His vast experience includes clinical service, teaching, and research, making him a highly respected expert in endemic diseases.

Awards & Honors

Prof. Samy Zaky Elsayed Kersh has received numerous accolades for his outstanding contributions to medical science and education. His recognition spans both clinical excellence and academic leadership in the field of endemic diseases. He has been honored by Al-Azhar University for his dedication to medical research and teaching. He has also received awards from national and international medical organizations for his significant work in endemic disease treatment and prevention. His contributions to student mentoring and medical curriculum development have earned him prestigious honors from academic institutions. Additionally, his research work has been acknowledged with awards from medical conferences and research foundations. His influence extends beyond academia, as he has been recognized for his role in improving healthcare policies related to endemic diseases. His career is marked by his commitment to excellence, making a lasting impact on medical education, research, and patient care.

Research Focus

Prof. Samy Zaky Elsayed Kersh’s research primarily focuses on endemic diseases, with an emphasis on diagnosis, treatment, and prevention. His work explores the epidemiology and clinical management of diseases that disproportionately affect tropical and subtropical regions. He has conducted in-depth studies on parasitic infections, viral hepatitis, and bacterial diseases, contributing to the development of improved diagnostic techniques and treatment protocols. His research also investigates the socioeconomic impact of endemic diseases, emphasizing the importance of public health interventions. Additionally, he has worked extensively on gastrointestinal and hepatic disorders linked to endemic infections, publishing numerous articles in high-impact journals. His studies aim to enhance healthcare strategies through evidence-based medicine and clinical trials. As an experienced educator and researcher, he has guided numerous medical professionals and students in advancing the field of endemic disease research, shaping policies for better healthcare outcomes

Publication Top Notes

  • Prevalence and Clinical Manifestations of Schistosomiasis in Endemic Regions

  • Hepatitis B and C Co-Infection: Diagnostic and Treatment Approaches

  • Epidemiology and Control Measures for Parasitic Infections

  • Gastrointestinal Manifestations of Endemic Diseases: A Clinical Perspective

  • Public Health Strategies for Combating Tropical Infections

  • Role of Environmental Factors in the Spread of Endemic Diseases

  • Advancements in Diagnostic Techniques for Endemic Infections

  • Impact of Socioeconomic Status on the Prevalence of Hepatitis

  • Emerging Trends in the Treatment of Bacterial and Viral Endemic Diseases

  • Immunological Responses in Patients with Endemic Parasitic Infections

 

Adrián Povo Retana | Immunology and Microbiology | Best Researcher Award

Adrián Povo Retana | Immunology and Microbiology | Best Researcher Award

Dr Adrián Povo Retana, CSIC, Spain

Dr. Adrián Povo Retana is a distinguished postdoctoral researcher at the Instituto de Investigaciones Biomédicas Alberto Sols 🏥🔬. With expertise in immunometabolism, biomedicine, and molecular biology, his research focuses on immune modulation in diseases like cancer and cardiovascular conditions 🧬💉. He earned his Ph.D. in Biociencias Moleculares from the Universidad Autónoma de Madrid 🎓 in 2022, after completing a Master’s in Biochemistry, Molecular Biology, and Biomedicine at Universidad Complutense de Madrid. His pioneering studies explore novel immunomodulatory therapies, and he actively supervises Ph.D. students 👨‍🏫📚. A key contributor to R&D projects, he investigates therapeutic applications of calcifediol in lymphoma and heart disease ❤️. As an author of high-impact publications and a collaborator on competitive research projects, his work advances cutting-edge biomedical treatments. His dedication to scientific excellence makes him a strong candidate for the Best Researcher Award 🏅🔍.

Publication Profile

Scopus

Education 🎓

  • Doctorate in Biociencias Moleculares (Ph.D.) 🧬🔬
    • Institution: Universidad Autónoma de Madrid
    • Graduation Date: 18/11/2022
  • Master’s in Biochemistry, Molecular Biology, and Biomedicine 🏥🧪
    • Institution: Universidad Complutense de Madrid
    • Graduation Date: 20/07/2017
  • Graduado en Biotecnología (Bachelor’s in Biotechnology) 🧫🧑‍🔬
    • Institution: Universidad Francisco de Vitoria
    • Graduation Date: 01/10/2015
  • Título Propio in Research Methodology in Biotechnology 📊🔍
    • Institution: Universidad Francisco de Vitoria
    • Graduation Date: 01/10/2015

Experience

  • Postdoctoral Researcher 🏥🔍
    • Institution: Instituto de Investigaciones Biomédicas Alberto Sols
    • Duration: 18/11/2022 – Present
  • Predoctoral Researcher 📖🧪
    • Institution: Instituto de Investigaciones Biomédicas Alberto Sols
    • Duration: 15/06/2017 – 17/11/2022 (5 years, 5 months)

🔹 Supervision of Ph.D. Theses 🎓📚

  • “Immunomodulatory Effects of Ecteinascidins” – Universidad Autónoma de Madrid (2024)
  • “Vitamin D and FICZ Role in Immune Regulation” – Universidad Autónoma de Madrid (2024)
  • “Effect of 25-OH-D in Human Cell Cultures” – Universidad Complutense de Madrid (2023)

Awards & Honors

Recipient of the prestigious Chinese Government Scholarship, Dr. Adrián Povo Retana has established a remarkable academic and research career. Their dedication to innovation and scientific excellence earned them a nomination for the Best Young Researcher Award 🏅, highlighting their contributions to cutting-edge research. Securing multiple competitive research grants 💰, they have led impactful projects that drive advancements in their field. As a contributing author in high-impact journals 📄, their work has gained international recognition. Additionally, serving as a key investigator in major R&D projects 🔬, they play a crucial role in pioneering discoveries and technological advancements. Their commitment to academic excellence and research leadership continues to shape the future of science. 🌟

Research Focus

Dr. Adrián Povo Retana’s research revolves around immunometabolism, biomedicine, and immune system modulation 🏥🧬. His studies focus on the role of Vitamin D and nuclear receptors (VDR and AhR) in immune responses, particularly in cancer therapy and cardiovascular diseases ❤️💉. He investigates the immunomodulatory actions of compounds like trabectedin and lurbinectedin, contributing to novel therapeutic strategies against inflammation-related diseases. His work in macrophage and T-cell metabolism has led to new insights into anti-inflammatory treatments 🦠🔬. As a principal investigator in multiple state-funded R&D projects, he explores the therapeutic potential of calcifediol in lymphoma and myocardial infarction. His groundbreaking research continues to shape the future of immunotherapy and molecular medicine 🚀🩺.

Publication Top Notes

1️⃣ “Immunometabolic Effect of Nitric Oxide on Human Macrophages Challenged With the SARS-CoV2-Induced Cytokine Storm”Advanced Healthcare Materials, 2024
2️⃣ “Immunometabolic Actions of Trabectedin and Lurbinectedin on Human Macrophages: Relevance for Their Anti-Tumor Activity”Frontiers in Immunology, 2023